Dialysis timing may be deferred toward very late initiation: An observational study

The optimal timing to initiate dialysis among patients with an estimated glomerular filtration rate (eGFR) of

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2020-05, Vol.15 (5), p.e0233124-e0233124
Hauptverfasser: Chang, Yun-Lun, Wang, Jie-Sian, Yeh, Hung-Chieh, Ting, I-Wen, Huang, Han-Chun, Chiang, Hsiu-Yin, Hsiao, Chiung-Tzu, Chu, Pei-Lun, Kuo, Chin-Chi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0233124
container_issue 5
container_start_page e0233124
container_title PloS one
container_volume 15
creator Chang, Yun-Lun
Wang, Jie-Sian
Yeh, Hung-Chieh
Ting, I-Wen
Huang, Han-Chun
Chiang, Hsiu-Yin
Hsiao, Chiung-Tzu
Chu, Pei-Lun
Kuo, Chin-Chi
description The optimal timing to initiate dialysis among patients with an estimated glomerular filtration rate (eGFR) of
doi_str_mv 10.1371/journal.pone.0233124
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2402401177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A623752658</galeid><doaj_id>oai_doaj_org_article_11baa869f84246b6bfd87062a9e41ccb</doaj_id><sourcerecordid>A623752658</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-5c77286d2142aef52e9b645ef0f83bcb79781eb78c441608d92c998e0349f9db3</originalsourceid><addsrcrecordid>eNqNkl9v0zAUxSMEYmPwDRBEQkLw0BLbie3wgFSNf5UmTWLAq-U4N60rJy62U-i3x2mzqUF7QHlIbP_uuTnXJ0meo2yOCEPvNrZ3nTTzre1gnmFCEM4fJOeoJHhGcUYennyfJU-832RZQTilj5MzgvMMccTOk5uPWpq91z4NutXdKm3lPq0graEB56BOg_0tXZ3uwO1TIwOkutNBy6Bt9z5ddKmtPLjdYS1N6kNf758mjxppPDwb3xfJj8-fvl9-nV1df1leLq5mipY4zArFGOa0xijHEpoCQ1nRvIAmazipVMVKxhFUjKs8RzTjdYlVWXLISF42ZV2Ri-TlUXdrrBfjPLyI3gZ7iLFILI9EbeVGbJ1updsLK7U4bFi3EtIFrQwIhCopOS0bnuOcVrRqas4yimUJOVJq6PZh7NZXLdQKuuCkmYhOTzq9Fiu7Ewyj6ARHgTejgLO_evBBtNorMEZ2YPvDf5MMc14M6Kt_0PvdjdRKRgO6a2zsqwZRsaCYsALTgkdqfg8VnxparWJ4Gh33JwVvJwWRCfAnrGTvvVjefPt_9vrnlH19wq5BmrD21vRDdPwUzI-gctZ7B83dkFEmhuzfTkMM2Rdj9mPZi9MLuiu6DTv5C80j_gw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2402401177</pqid></control><display><type>article</type><title>Dialysis timing may be deferred toward very late initiation: An observational study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Chang, Yun-Lun ; Wang, Jie-Sian ; Yeh, Hung-Chieh ; Ting, I-Wen ; Huang, Han-Chun ; Chiang, Hsiu-Yin ; Hsiao, Chiung-Tzu ; Chu, Pei-Lun ; Kuo, Chin-Chi</creator><contributor>Andreucci, Michele</contributor><creatorcontrib>Chang, Yun-Lun ; Wang, Jie-Sian ; Yeh, Hung-Chieh ; Ting, I-Wen ; Huang, Han-Chun ; Chiang, Hsiu-Yin ; Hsiao, Chiung-Tzu ; Chu, Pei-Lun ; Kuo, Chin-Chi ; Andreucci, Michele</creatorcontrib><description>The optimal timing to initiate dialysis among patients with an estimated glomerular filtration rate (eGFR) of &lt;5 mL/min/1.73 m2 is unknown. We hypothesized that dialysis initiation time can be deferred in this population even with high uremic burden. A case-crossover study with case (0-30 days before dialysis initiation [DI]) and control (90-120 days before DI) periods was conducted in 1,079 hemodialysis patients aged 18-90 years at China Medical University Hospital between 2006 and 2015. The uremic burden was quantified based on 7 uremic indicators that reached the predefined threshold in case period, namely hemoglobin, serum albumin, blood urea nitrogen, serum creatinine, potassium, phosphorus, and bicarbonate. Dialysis timing was classified as standard (met 0-2 uremic indicators), late (3-5 indicators), and very late (6-7 indicators). Median eGFR-DI of the 1,079 patients was 3.4 mL/min/1.73 m2 and was 2.7 mL/min/1.73 m2 in patients with very late initiation. The median follow-up duration was 2.42 years. Antibiotics, diuretics, antihypertensive medications, and non-steroidal anti-inflammatory drugs (NSAIDs) were more prevalently used during the case period. The fully adjusted hazards ratios of all-cause mortality for the late and very late groups were 0.97 (95% confidence interval 0.76-1.24) and 0.83 (0.61-1.15) compared with the standard group. It is safe to defer dialysis initiation among patients with chronic kidney disease (CKD) having an eGFR of &lt;5 mL/min/1.73 m2 even when patients having multiple biochemical uremic burdens. Coordinated efforts in acute infection prevention, optimal fluid management, and prevention of accidental exposure to NSAIDs are crucial to prolong the dialysis-free survival.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0233124</identifier><identifier>PMID: 32401817</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Accreditation ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Albumin ; Anti-inflammatory agents ; Antibiotics ; Antihypertensives ; Bicarbonates ; Big Data ; Biology and Life Sciences ; Carbon dioxide ; Carbonates ; Care and treatment ; Chronic kidney failure ; Computer centers ; Confidence intervals ; Creatinine ; Dialysis ; Diseases ; Diuretics ; Epidermal growth factor receptors ; Female ; Fluid management ; Glomerular filtration rate ; Glycosylated hemoglobin ; Hemodialysis ; Hemoglobin ; Hemoglobins ; Hospitals ; Humans ; Indicators ; Inflammation ; Internal medicine ; Kidney diseases ; Laboratories ; Male ; Medical research ; Medical schools ; Medicine ; Medicine and Health Sciences ; Methods ; Middle Aged ; Mortality ; Nephrology ; Nonsteroidal anti-inflammatory drugs ; Observational studies ; Observational Studies as Topic ; Patient outcomes ; Patients ; Phosphorus ; Potassium ; Prevention ; Proportional Hazards Models ; Renal Dialysis - methods ; Serum albumin ; Steroidal anti-inflammatory agents ; Time ; Time Factors ; Urea ; Young Adult</subject><ispartof>PloS one, 2020-05, Vol.15 (5), p.e0233124-e0233124</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Chang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Chang et al 2020 Chang et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-5c77286d2142aef52e9b645ef0f83bcb79781eb78c441608d92c998e0349f9db3</citedby><cites>FETCH-LOGICAL-c692t-5c77286d2142aef52e9b645ef0f83bcb79781eb78c441608d92c998e0349f9db3</cites><orcidid>0000-0002-2050-1377</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219782/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219782/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32401817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Andreucci, Michele</contributor><creatorcontrib>Chang, Yun-Lun</creatorcontrib><creatorcontrib>Wang, Jie-Sian</creatorcontrib><creatorcontrib>Yeh, Hung-Chieh</creatorcontrib><creatorcontrib>Ting, I-Wen</creatorcontrib><creatorcontrib>Huang, Han-Chun</creatorcontrib><creatorcontrib>Chiang, Hsiu-Yin</creatorcontrib><creatorcontrib>Hsiao, Chiung-Tzu</creatorcontrib><creatorcontrib>Chu, Pei-Lun</creatorcontrib><creatorcontrib>Kuo, Chin-Chi</creatorcontrib><title>Dialysis timing may be deferred toward very late initiation: An observational study</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The optimal timing to initiate dialysis among patients with an estimated glomerular filtration rate (eGFR) of &lt;5 mL/min/1.73 m2 is unknown. We hypothesized that dialysis initiation time can be deferred in this population even with high uremic burden. A case-crossover study with case (0-30 days before dialysis initiation [DI]) and control (90-120 days before DI) periods was conducted in 1,079 hemodialysis patients aged 18-90 years at China Medical University Hospital between 2006 and 2015. The uremic burden was quantified based on 7 uremic indicators that reached the predefined threshold in case period, namely hemoglobin, serum albumin, blood urea nitrogen, serum creatinine, potassium, phosphorus, and bicarbonate. Dialysis timing was classified as standard (met 0-2 uremic indicators), late (3-5 indicators), and very late (6-7 indicators). Median eGFR-DI of the 1,079 patients was 3.4 mL/min/1.73 m2 and was 2.7 mL/min/1.73 m2 in patients with very late initiation. The median follow-up duration was 2.42 years. Antibiotics, diuretics, antihypertensive medications, and non-steroidal anti-inflammatory drugs (NSAIDs) were more prevalently used during the case period. The fully adjusted hazards ratios of all-cause mortality for the late and very late groups were 0.97 (95% confidence interval 0.76-1.24) and 0.83 (0.61-1.15) compared with the standard group. It is safe to defer dialysis initiation among patients with chronic kidney disease (CKD) having an eGFR of &lt;5 mL/min/1.73 m2 even when patients having multiple biochemical uremic burdens. Coordinated efforts in acute infection prevention, optimal fluid management, and prevention of accidental exposure to NSAIDs are crucial to prolong the dialysis-free survival.</description><subject>Accreditation</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Albumin</subject><subject>Anti-inflammatory agents</subject><subject>Antibiotics</subject><subject>Antihypertensives</subject><subject>Bicarbonates</subject><subject>Big Data</subject><subject>Biology and Life Sciences</subject><subject>Carbon dioxide</subject><subject>Carbonates</subject><subject>Care and treatment</subject><subject>Chronic kidney failure</subject><subject>Computer centers</subject><subject>Confidence intervals</subject><subject>Creatinine</subject><subject>Dialysis</subject><subject>Diseases</subject><subject>Diuretics</subject><subject>Epidermal growth factor receptors</subject><subject>Female</subject><subject>Fluid management</subject><subject>Glomerular filtration rate</subject><subject>Glycosylated hemoglobin</subject><subject>Hemodialysis</subject><subject>Hemoglobin</subject><subject>Hemoglobins</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Indicators</subject><subject>Inflammation</subject><subject>Internal medicine</subject><subject>Kidney diseases</subject><subject>Laboratories</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical schools</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Nephrology</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Observational studies</subject><subject>Observational Studies as Topic</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Phosphorus</subject><subject>Potassium</subject><subject>Prevention</subject><subject>Proportional Hazards Models</subject><subject>Renal Dialysis - methods</subject><subject>Serum albumin</subject><subject>Steroidal anti-inflammatory agents</subject><subject>Time</subject><subject>Time Factors</subject><subject>Urea</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl9v0zAUxSMEYmPwDRBEQkLw0BLbie3wgFSNf5UmTWLAq-U4N60rJy62U-i3x2mzqUF7QHlIbP_uuTnXJ0meo2yOCEPvNrZ3nTTzre1gnmFCEM4fJOeoJHhGcUYennyfJU-832RZQTilj5MzgvMMccTOk5uPWpq91z4NutXdKm3lPq0graEB56BOg_0tXZ3uwO1TIwOkutNBy6Bt9z5ddKmtPLjdYS1N6kNf758mjxppPDwb3xfJj8-fvl9-nV1df1leLq5mipY4zArFGOa0xijHEpoCQ1nRvIAmazipVMVKxhFUjKs8RzTjdYlVWXLISF42ZV2Ri-TlUXdrrBfjPLyI3gZ7iLFILI9EbeVGbJ1updsLK7U4bFi3EtIFrQwIhCopOS0bnuOcVrRqas4yimUJOVJq6PZh7NZXLdQKuuCkmYhOTzq9Fiu7Ewyj6ARHgTejgLO_evBBtNorMEZ2YPvDf5MMc14M6Kt_0PvdjdRKRgO6a2zsqwZRsaCYsALTgkdqfg8VnxparWJ4Gh33JwVvJwWRCfAnrGTvvVjefPt_9vrnlH19wq5BmrD21vRDdPwUzI-gctZ7B83dkFEmhuzfTkMM2Rdj9mPZi9MLuiu6DTv5C80j_gw</recordid><startdate>20200513</startdate><enddate>20200513</enddate><creator>Chang, Yun-Lun</creator><creator>Wang, Jie-Sian</creator><creator>Yeh, Hung-Chieh</creator><creator>Ting, I-Wen</creator><creator>Huang, Han-Chun</creator><creator>Chiang, Hsiu-Yin</creator><creator>Hsiao, Chiung-Tzu</creator><creator>Chu, Pei-Lun</creator><creator>Kuo, Chin-Chi</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2050-1377</orcidid></search><sort><creationdate>20200513</creationdate><title>Dialysis timing may be deferred toward very late initiation: An observational study</title><author>Chang, Yun-Lun ; Wang, Jie-Sian ; Yeh, Hung-Chieh ; Ting, I-Wen ; Huang, Han-Chun ; Chiang, Hsiu-Yin ; Hsiao, Chiung-Tzu ; Chu, Pei-Lun ; Kuo, Chin-Chi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-5c77286d2142aef52e9b645ef0f83bcb79781eb78c441608d92c998e0349f9db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Accreditation</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Albumin</topic><topic>Anti-inflammatory agents</topic><topic>Antibiotics</topic><topic>Antihypertensives</topic><topic>Bicarbonates</topic><topic>Big Data</topic><topic>Biology and Life Sciences</topic><topic>Carbon dioxide</topic><topic>Carbonates</topic><topic>Care and treatment</topic><topic>Chronic kidney failure</topic><topic>Computer centers</topic><topic>Confidence intervals</topic><topic>Creatinine</topic><topic>Dialysis</topic><topic>Diseases</topic><topic>Diuretics</topic><topic>Epidermal growth factor receptors</topic><topic>Female</topic><topic>Fluid management</topic><topic>Glomerular filtration rate</topic><topic>Glycosylated hemoglobin</topic><topic>Hemodialysis</topic><topic>Hemoglobin</topic><topic>Hemoglobins</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Indicators</topic><topic>Inflammation</topic><topic>Internal medicine</topic><topic>Kidney diseases</topic><topic>Laboratories</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical schools</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Nephrology</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Observational studies</topic><topic>Observational Studies as Topic</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Phosphorus</topic><topic>Potassium</topic><topic>Prevention</topic><topic>Proportional Hazards Models</topic><topic>Renal Dialysis - methods</topic><topic>Serum albumin</topic><topic>Steroidal anti-inflammatory agents</topic><topic>Time</topic><topic>Time Factors</topic><topic>Urea</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Yun-Lun</creatorcontrib><creatorcontrib>Wang, Jie-Sian</creatorcontrib><creatorcontrib>Yeh, Hung-Chieh</creatorcontrib><creatorcontrib>Ting, I-Wen</creatorcontrib><creatorcontrib>Huang, Han-Chun</creatorcontrib><creatorcontrib>Chiang, Hsiu-Yin</creatorcontrib><creatorcontrib>Hsiao, Chiung-Tzu</creatorcontrib><creatorcontrib>Chu, Pei-Lun</creatorcontrib><creatorcontrib>Kuo, Chin-Chi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Yun-Lun</au><au>Wang, Jie-Sian</au><au>Yeh, Hung-Chieh</au><au>Ting, I-Wen</au><au>Huang, Han-Chun</au><au>Chiang, Hsiu-Yin</au><au>Hsiao, Chiung-Tzu</au><au>Chu, Pei-Lun</au><au>Kuo, Chin-Chi</au><au>Andreucci, Michele</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dialysis timing may be deferred toward very late initiation: An observational study</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2020-05-13</date><risdate>2020</risdate><volume>15</volume><issue>5</issue><spage>e0233124</spage><epage>e0233124</epage><pages>e0233124-e0233124</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The optimal timing to initiate dialysis among patients with an estimated glomerular filtration rate (eGFR) of &lt;5 mL/min/1.73 m2 is unknown. We hypothesized that dialysis initiation time can be deferred in this population even with high uremic burden. A case-crossover study with case (0-30 days before dialysis initiation [DI]) and control (90-120 days before DI) periods was conducted in 1,079 hemodialysis patients aged 18-90 years at China Medical University Hospital between 2006 and 2015. The uremic burden was quantified based on 7 uremic indicators that reached the predefined threshold in case period, namely hemoglobin, serum albumin, blood urea nitrogen, serum creatinine, potassium, phosphorus, and bicarbonate. Dialysis timing was classified as standard (met 0-2 uremic indicators), late (3-5 indicators), and very late (6-7 indicators). Median eGFR-DI of the 1,079 patients was 3.4 mL/min/1.73 m2 and was 2.7 mL/min/1.73 m2 in patients with very late initiation. The median follow-up duration was 2.42 years. Antibiotics, diuretics, antihypertensive medications, and non-steroidal anti-inflammatory drugs (NSAIDs) were more prevalently used during the case period. The fully adjusted hazards ratios of all-cause mortality for the late and very late groups were 0.97 (95% confidence interval 0.76-1.24) and 0.83 (0.61-1.15) compared with the standard group. It is safe to defer dialysis initiation among patients with chronic kidney disease (CKD) having an eGFR of &lt;5 mL/min/1.73 m2 even when patients having multiple biochemical uremic burdens. Coordinated efforts in acute infection prevention, optimal fluid management, and prevention of accidental exposure to NSAIDs are crucial to prolong the dialysis-free survival.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>32401817</pmid><doi>10.1371/journal.pone.0233124</doi><tpages>e0233124</tpages><orcidid>https://orcid.org/0000-0002-2050-1377</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2020-05, Vol.15 (5), p.e0233124-e0233124
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2402401177
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Accreditation
Adolescent
Adult
Aged
Aged, 80 and over
Albumin
Anti-inflammatory agents
Antibiotics
Antihypertensives
Bicarbonates
Big Data
Biology and Life Sciences
Carbon dioxide
Carbonates
Care and treatment
Chronic kidney failure
Computer centers
Confidence intervals
Creatinine
Dialysis
Diseases
Diuretics
Epidermal growth factor receptors
Female
Fluid management
Glomerular filtration rate
Glycosylated hemoglobin
Hemodialysis
Hemoglobin
Hemoglobins
Hospitals
Humans
Indicators
Inflammation
Internal medicine
Kidney diseases
Laboratories
Male
Medical research
Medical schools
Medicine
Medicine and Health Sciences
Methods
Middle Aged
Mortality
Nephrology
Nonsteroidal anti-inflammatory drugs
Observational studies
Observational Studies as Topic
Patient outcomes
Patients
Phosphorus
Potassium
Prevention
Proportional Hazards Models
Renal Dialysis - methods
Serum albumin
Steroidal anti-inflammatory agents
Time
Time Factors
Urea
Young Adult
title Dialysis timing may be deferred toward very late initiation: An observational study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A19%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dialysis%20timing%20may%20be%20deferred%20toward%20very%20late%20initiation:%20An%20observational%20study&rft.jtitle=PloS%20one&rft.au=Chang,%20Yun-Lun&rft.date=2020-05-13&rft.volume=15&rft.issue=5&rft.spage=e0233124&rft.epage=e0233124&rft.pages=e0233124-e0233124&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0233124&rft_dat=%3Cgale_plos_%3EA623752658%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2402401177&rft_id=info:pmid/32401817&rft_galeid=A623752658&rft_doaj_id=oai_doaj_org_article_11baa869f84246b6bfd87062a9e41ccb&rfr_iscdi=true